COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 2006: Articles 20051-20060  | Next

One Year of SARS-CoV-2: How Much Has the Virus Changed?
Vilar, S., Isom, D. G.
10.1101/2020.12.16.423071 — Posted: 2020-12-16
EXPERIMENTAL INVESTIGATION OF PULSE STERILIZATION OF VIRAL INFECTION
Chumakov, V. I., Ostryzhny, M., Kharchenko, O., Naumenko, K., Zagorodnya, S., Muraveinyk, V., Tarasevich, A.
10.1101/2020.12.16.423002 — Posted: 2020-12-16
Niclosamide inhibits SARS-CoV2 entry by blocking internalization through pH-dependent CLIC/GEEC endocytic pathway
Prabhakara, C., Godbole, R., Sil, P., Jahnavi, S., van Zanten, T. S., Sheth, D., Subhash, N., Chandra, A., Nuthakki, V. K., Puthiyapurayil, T. P., Ahmed, R., Najar, A. H., Lingamallu, S. M., Das, S., Mahajan, B., Vemula, P. K., Bharate, S. B., Singh, P. P., Vishwakarma, R., Guha, A., Sundaramurthy, V., Mayor, S.
10.1101/2020.12.16.422529 — Posted: 2020-12-16
Detection of long SARS-CoV-2 nucleocapsid sequences in peripheral blood monocytes collected soon after hospital admission
Pagano, N., Laurent-Rolle, M., Hsu, J. C., Yale IMPACT Research Team, , Vogels, C. B., Grubaugh, N. D., Manuelidis, L.
10.1101/2020.12.16.423113 — Posted: 2020-12-16 Discussion: Onsite
Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in-vitro repurposing screen
Kuzikov, M., Costanzi, E., Reinshagen, J., Esposito, F., Vangeel, L., Wolf, M., Ellinger, B., Claussen, C., Geisslinger, G., Corona, A., Iaconis, D., Talarico, C., Manelfi, C., Cannalire, R., Rossetti, G., Gossen, J., Albani, S., Musiani, F., Herzog, K., Ye, Y., Giabbai, B., Demitri, N., Jochmans, D., De Jonghe, S., Rymenants, J., Summa, V., Tramontano, E., Beccari, A. R., Leyssen, P., Storici, P., Neyts, J., Gribbon, P., Zaliani, A.
10.1101/2020.12.16.422677 — Posted: 2020-12-16
Choice of assemblers has a critical impact on de novo assembly of SARS-CoV-2 genome and characterizing variants
Islam, R., Raju, R. S., Tasnim, N., Shihab, M. I. H., Bhuiyan, M. A., Araf, Y., Islam, T.
10.1101/2020.12.15.422939 — Posted: 2020-12-16
Cyclic gallium-68 labeled peptides for specific detection of human angiotensin-converting enzyme 2
Parker, M., Blecha, J., Rosenberg, O., Ohliger, M., Flavell, R., Wilson, D. M.
10.1101/2020.12.15.412809 — Posted: 2020-12-16
Remdesivir is a delayed translocation inhibitor of SARS CoV-2 replication in vitro
Bravo, J. P., Dangerfield, T. L., Taylor, D. W., Johnson, K. A.
10.1101/2020.12.14.422718 — Posted: 2020-12-16
Characteristics and Risk Factors for Hospitalization and Mortality among Persons with COVID-19 in Atlanta Metropolitan Area
Chishinga, N., Gandhi, N. R., Onwubiko, U. N., Telford, C., Prieto, J., Smith, S., Chamberlain, A. T., Khan, S., Williams, S., Khan, F., Shah, S.
10.1101/2020.12.15.20248214 — Posted: 2020-12-16
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity
Fadista, J., Kraven, L. M., Karjalainen, J., Andrews, S. J., Geller, F., The COVID-19 Host Genetics Initiative, , Baillie, J. K., Wain, L. V., Gisli Jenkins, R., Feenstra, B.
10.1101/2020.12.15.20248279 — Posted: 2020-12-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).